Lara Longpre - 08 Jan 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
08 Jan 2024
Net transactions value
-$28,568
Form type
4
Filing time
09 Jan 2024, 20:25:28 UTC
Previous filing
15 Nov 2023
Next filing
25 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale $28,568 -1,019 -0.96% $28.04 105,254 08 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.